97258 ⎘
Immunoglobulins specific features characterized by taxonomic origin
Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulin
#302Methods and compositions for treating fibrotic diseases
#303Immunoassays of s-adenosylmethionine and methylation index in personalized medicine and health evaluation
#304METHODS FOR IDENTIFYING IMMUNOBINDERS OF CELL-SURFACE ANTIGENS
#305Method for the treatment of epilepsy, epileptogenesis, seizures or convulsions by an anti-colony-stimulating factor 1 receptor (CSF-1R) antibody
#306Anti-LAG-3 antibodies and methods of use thereof
#307MULTI-ARM LINKERS FOR CONSTRUCTING PHARMACEUTICAL MOLECULES
#308Filovirus therapy
#309Methods of treating autoimmunity using specific anti-IL-6 antibodies
#310Antigen binding molecules specific for an anti-CD19 scFv
#311PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS
#312Polyomavirus neutralizing antibodies
#313Systems and methods for anti-SOX10 antibodies
#314ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPY
#315Monoclonal antibodies against amyloid beta protein and uses thereof
#316Anti-hepcidin antibodies and uses thereof
#317Methods of delivering DLL3 antibody drug conjugates
#318Methods of making DLL3 antibody drug conjugates
#319EQUINE IMMUNOGLOBULIN COMPOSITIONS AND USES FOR TREATING FILOVIRUS-MEDIATED DISEASES
#320Pharmaceutical composition for preventing or treating cancer and method using thereof
#321Anti-DLL3 antibody drug conjugates and methods of use
#322Production of Motif-Specific and Context-Independent Antibodies Using Peptide Libraries as Antigens
#323Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
#324Method for producing a recombinant allotypespecific rabbit monoclonal antibody
#325Anti-DLL3 antibody drug conjugates
#326TEM-1 diagnostic antibodies
#327Monoclonal antibodies and methods of use
#328TfR selective binding compounds and related methods
#329Anti-complement factor C1q antibodies and uses thereof
#330Methods of Treating Autoimmune Diseases
#331Anti-NTB-A antibodies and related compositions and methods
#332ANTI-RSPO3 ANTIBODIES AND METHODS OF USE
#333Cervical cancer-related HPV E7 protein monoclonal antibody and use thereof
#334Kits containing DLL3 antibody drug conjugates
#335Transgenic mammals and methods of use thereof
#336PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION AND TREATMENT, CONTAINING NDRG3 EXPRESSION OR ACTIVITY INHIBITOR AS ACTIVE INGREDIENT, OR NDRG3 PROTEIN-SPECIFIC ANTIBODY AND USE THEREOF
#337Method for producing antigen-specific B cells and their use for the production of hybridoma cells and monoclonal antibodies
#338COMPLIMENT FACTOR I BIOASSAY
#339Anti-hepcidin antibodies and uses thereof
#340METHODS, CELLS & ORGANISMS
#341NEUTRALISING ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-17
#342Anti-DLL3 antibody drug conjugates
#343Anti-sortilin antibodies, uses and methods for treatment
#344Anti-DLL3 antibody drug conjugates for treating cancer
#345Methods of making DLL3 antibody drug conjugates
#346Methods of delivering DLL3 antibody drug conjugates
#347Anti-DLL3 antibody drug conjugates
#348STIMULI-RESPONSIVE PROTEIN-POLYMER CONJUGATES FOR BIOSEPARATION
#349Anti-PDGF-B antibodies and methods of use
#350SHARK ANTIBODIES FOR CANCER THERAPY
#351Method for producing polyclonal antibodies with improved complement-dependent cytotoxicity
#352Methods of treating inflammation using IL-17A and IL-17F cross-reactive monoclonal antibodies
#353Semi-synthetic nurse shark VNAR libraries for making and using selective binding compounds
#354HYPOGLYCEMIC AGENT CONTAINING ANTI-ANG2 ANTIBODY
#355Rodent combinatorial antibody libraries
#356Treatment of fibrosis
#357Biotin Derivatives
#358Host cells for use in an inducible coexpression system
#359Anti-canine PD-1 antibody or anti-canine PD-L1 antibody
#360Anti-indoleamine 2,3-dioxygenase 1 antibodies and diagnostic uses thereof
#361Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
#362vNAR recombinant monoclonal antibodies that neutralize vascular endophelial growth factor VEGF
#363Anti human Notch4 antibody
#364METHODS AND COMPOSITIONS RELATED TO AMYLOID-BETA-42 OLIGOMERS
#365Methods and diagnostics for cancer detection and treatment monitoring
#366Hybridoma cell lines (my-C-CC0C2-235-3H8) and use thereof for producing a monoclonal antibody against the human cardiac myosin binding protein C (C-protein, MYBPC3, CMYBP-C or MY-C)
#367Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV
#368Method of promoting wound healing with hyodxia-induced mitogenic factor
#369ENHANCED PRODUCTION OF IMMUNOGLOBULINS
#370Fusion protein for treating rejection reaction in transplantation
#371Multi-arm linker for treating rejection reaction in transplantation
#372Pharmaceuticals in joint-linker configurations for treating pathological blood clots
#373Multi-arm linker constructs for treating pathological blood clots
#374ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPY
#375Polynucleotides encoding VNAR anti-cytokine domains
#376Murine anti-NY-ESO-1 T cell receptors
#377Anti-DLL3 antibody drug conjugates for treating cancer
#378PD-1 antibody, antigen-binding fragment thereof, and medical application thereof
#379Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity
#380Systems and Methods for Anti-PAX8 Antibodies
#381CYS80 conjugated immunoglobulins
#382Immunoglobulin-like molecules directed against fibronectin-EDA
#383Anti-complement factor C1q antibodies and uses thereof
#384Cell lines expressing surface bound anti-idiotype antibodies against anti-CD22 antibodies and uses thereof
#385Secretory IgA compositions, methods of making and methods of use thereof
#386Diagnosis of a neuroautoimmune disease comprising measuring autoantibodies to flotillin1 and/or flotillin2
#387Anti-Uroplakin II antibodies systems and methods
#388Baff selective binding compounds and related methods
#389METHODS AND COMPOSITIONS FOR MODULATION OF OLFML3 MEDIATED ANGIOGENESIS
#390BIOLOGICAL PRODUCTS
#391Monoclonal antibody capable of binding integrin alpha 10 beta 1
#392Motif-Specific and Context-Independent Antibodies That Specifically Bind to a Cleaved Caspase Motif
#393SEZ6 modulators and methods of use
#394Method for making heteromultimeric molecules
#395Compositions and methods for detecting and/or treating inflammation
#396PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS
#397ANTI-PODOCALYXIN ANTIBODIES AND METHODS OF USING THE SAME
#398Methods, Cells & Organisms
#399Anti-DLL3 antibody drug conjugates
#400NEUTRALISING ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-17
#401Anti-LPS enriched immunoglobulin for use in treatment and/or prophylaxis of fibrosis
#402Binding Moieties Based On Shark IgNAR Domains
#403Antibodies for botulinum neurotoxins
#404TUMOR SELECTIVE ANTIBODIES SPECIFIC TO ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR PROTEIN
#405Method for producing polypeptide heteromultimer
#406Anti-EGFR activatable antibodies
#407COMBINATIONS OF AGGREGATING PROTEINS AND MOLECULAR CHAPERONE PROTEINS FOR THE TREATMENT OF PROTEINOPATHIES OR CONFORMATIONAL DISEASES
#408Anti-SOX10 antibody systems and methods
#409Peptide core-based multi-arm linkers
#410RECOMBINANT PLATELET COLLAGEN RECEPTOR GLYCOPROTEIN VI AND ITS PHARMACEUTICAL USE
#411Bacterial host strain
#412Method to generate antibodies to ion channels
#413NOVEL ACID AND CORRESPONDING PROTEIN ENTITLED 161P2F10B USEFUL IN TREATMENT AND DETECTION OF CANCER
#414Synthetic library of specific binding molecules
#415COMPOSITIONS AND METHODS FOR THE TREATMENT OF BURKHOLDERIA INFECTIONS
#416BAG3 receptor binding molecules for use as a medicament
#417Humanized antibodies with ultralong complementary determining regions
#418IL-17 RECEPTOR A IS REQUIRED FOR IL-17C BIOLOGY
#419Methods of modulating the activity of adrenomedullin in a subject in need of regulation of fluid balance by administering an anti-adrenomedullin (ADM) antibody or an anti-ADM antibody fragment
#420METHODS OF TREATMENT FOR ALZHEIMER'S DISEASE AND HUNTINGTON'S DISEASE
#421Humanized immunobinders of cell-surface antigens
#422Inducible expression system
#423Human anti-B7RP1 neutralizing antibodies
#424NOVEL ASSAY
#425METHODS AND CHARACTERISTICS FOR THE DIAGNOSIS OF ACUTE LYMPHOBLASTIC LEUKEMIA
#426Antigen binding protein and its use as addressing product for the treatment of cancer
#427ANTI-GCC ANTIBODY MOLECULES AND METHODS FOR USE OF SAME
#428COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
#429Chimeras of lumazine synthase and beta subunit of ABtoxins
#430Conjugates comprising cell-binding agents and cytotoxic agents
#431MOLECULAR LABELING METHODS
#432Isolation of therapeutic target specific VNAR domains to ICOSL
#433Melatonin monoclonal antibody, detection, methods and uses thereof
#434Antibody molecules
#435Immunoassays of S-adenosylmethionine and methylation index in personalized medicine and health evaluation
#436Monoclonal antibody for antagonizing and inhibiting binding of vascular endothelial growth factor to its receptor, and coding sequence
#437CHARGE-ENGINEERED ANTIBODIES OR COMPOSITIONS OF PENETRATION-ENHANCED TARGETING PROTEINS AND METHODS OF USE
#438Methods and compositions for the generation and use of conformation-specific antibodies
#439Epitope of RSV fusion protein and antibody recognizing the same
#440Anti-hepcidin antibodies and uses thereof
#441T CELL RECEPTOR MIMIC RL9A
#442Antibodies to argininosuccinate synthase and related methods
#443THERAPEUTIC AGENT
#444Anti-NTB-A antibodies and related compositions and methods
#445Dipeptide-repeat proteins as therapeutic target in neurodegenerative diseases with hexanucleotide repeat expansion
#446TEM-1 diagnostic antibodies
#447Use of DR6 Antagonists to Improve Motor Neuron Disease
#448ANTIBODY THERAPY FOR USE IN THE DIGESTIVE TRACT
#449Passive immunisation against influenza, in particular H5N1
#450METHOD OF PROTECTING CARDIAC FUNCTION
#451Immunoassay of S-adenosylmethionine in personalized medicine and health or cancer evaluation
#452VL ANTIGEN BINDING PROTEINS EXHIBITING DISTINCT BINDING CHARACTERISTICS
#453Production of motif-specific and context-independent antibodies using peptide libraries as antigens
#454TUMOR SELECTIVE ANTIBODIES SPECIFIC TO ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR PROTEIN
#455Treating anemia in chronic IL-6 associated diseases using anti-IL-6 antibodies
#456Mice that make heavy chain antibodies
#457Compositions Comprising an Anti-PDGF Aptamer and a VEGF Antagonist
#458ANTI-VEGF ANTIBODIES
#459Murine anti-NY-ESO-1 T cell receptors
#460Monoclonal canine CD20 antibodies and methods of use
#461DEVELOPMENT, CHARACTERIZATION, AND USE OF AN ANTI-HYPUSINATED eIF5A ANTIBODY TO DIAGNOSE DIABETES
#462Phosphine derivatives of fluorescent compounds
#463TNF-ALPHA BINDING PROTEINS
#464Cancer treatment and monitoring methods using OX40 agonists
#465MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN AND USES THEREOF
#466PROCESS FOR THE PREPARATION AND USE OF A BIVALENT VACCINE AGAINST MORPHINE-HEROIN ADDICTION
#467Antigen binding protein and its use as addressing product for the treatment of cancer
#468DEVELOPMENT OF SPECIFIC IMMUNOASSAY CRITICAL REAGENTS FOR PHARMACOKINETIC ASSESSMENTS OF PEPTIDE POLYMERS IN PRECLINICAL AND CLINICAL MATRICES
#469Methods for producing immunobinders of cell-surface antigens
#470DIAGNOSTIC KIT FOR THE DETECTION OF EARLY ACUTE LEPTOSPIROSIS
#471Monoclonal antibodies specific for the M2-1 antigen of respiratory syncytial virus (RSV)
#472Felinized antibodies and methods of treating retroviral infections in felines
#473Mice that make heavy chain antibodies
#474Engineered type IV pilin of
#475Methods and compositions for modulation of Olfml3 mediated angiogenisis
#476Compositions comprising TNF-specific antibodies for oral delivery and methods of use thereof to treat inflammatory bowel disease
#477Secretory IGA compositions, methods of making and methods of use thereof
#478Antibody production method
#479VNAR anti-cytokine domains
#480Method for selecting plasma cells or plasmablasts, method for producing target antigen specific antibodies, and novel monoclonal antibodies
#481Expression of antibody or a fragment thereof in lactobacillus
#482Method for making Heteromultimeric molecules
#483NOTCH inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof
#484Prevention and treatment of complement-associated eye conditions
#485FC RECEPTOR BINDING PROTEINS
#486Methods and compositions for modulation of Olfml3 mediated angiogenesis
#487Rodent combinatorial antibody libraries
#488Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
#489MILK DERIVED ANTIGEN SPECIFIC ANTIBODIES FOR INDUCING AN ADAPTIVE IMMUNE RESPONSE, METHODS OF PREPARATION AND USES THEREOF
#490Therapies for preventing or suppressing infection
#491Methods of treating mucositis using anti-TNF antibodies
#492BIOLOGICAL PRODUCTS
#493Use of goat serum for veterinary treatment
#494METHODS FOR IDENTIFYING IMMUNOBINDERS OF CELL-SURFACE ANTIGENS
#495TNFα-neutralizing antibodies
#496Method to generate antibodies to ion channels
#497Bacterial host strain
#498TNF-α binding proteins
#499Motif-specific and context-independent antibodies that specifically bind to a cleaved caspase motif
#500Modified antibody compositions, methods of making and using thereof
#501Methods and Compositions Related to Soluble Monoclonal Variable Lymphocyte Receptors of Defined Antigen Specificity
#502ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F AND METHODS OF USING THE SAME
#503Modified antibody compositions, methods of making and using thereof
#504Method of treating hypertrophic cardiomyopathy
#505ANTI-GPCR ANTIBODY AND THE METHOD OF PRODUCING THE SAME
#506Antibodies to toxins
#507Nucleic Acid Encoding TGEV and PRRSV Sequences for Improved Expression of PRRSV Sequences
#508Therapeutic Agent
#509Compositions and methods for detecting EGFR in cancer
#510Fusion Proteins Comprising Canine FC Portions
#511Humanized NSG mouse, method of producing the same and use thereof
#512Antibodies that bind tyrosyl-tRNA synthetases
#513Antigen binding domains
#514Method for treating pulmonary hypertension
#515Nucleic acid molecules encoding neutralising antibodies having specificity for human IL-17
#516Monoclonal antibody capable of binding integrin alpha 10 beta 1
#517Binding Moieties Based On Shark IgNAR Domains
#518Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction
#519ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F AND METHODS OF USING THE SAME
#520Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#521Monoclonal antibodies against amyloid beta protein and uses thereof
#522Prevention and treatment of complement-associated eye conditions
#523Amyloid-beta peptide crystal structure
#524Use a goat serum for veterinary treatment
#525TNFα-neutralizing antibodies
#526Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
#527Biological products
#528Single chain fragment variable antibody libraries and uses thereof
#529Mice that make heavy chain antibodies
#530Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma
#531VNAR anti-cytokine domains
#532Method for making heteromultimeric molecules
#533Human anti-B7RP1 neutralizing antibodies
#534ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F AND METHODS OF USING THE SAME
#535Treatment of MS with goat serum
#536Antibody-producing transgenic silkworms and methods for producing the same
#537Anti-VEGF antibodies
#538Hypoxia induced mitogenic factor
#539Antibody constant domain regions and uses thereof
#540Immunological targeting of pathological Tau proteins
#541Therapeutic Agent
#542Anti-IRC85 monoclonal antibody; and composition comprising the same for preventing and treating tuberculosis or enteritis disease; and the use thereof
#543Antibodies to IL-6 and use thereof
#544BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy
#545Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapy
#546Methods of using anti-TNF antibodies for treating radiation damage to the digestive tract
#547Methods for identifying immunobinders of cell-surface antigens
#548MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF
#549Methods of Treating Autoimmune Diseases
#550Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#551METHODS FOR USING ANTIBODIES AND ANALOGS THEREOF
#552H-Chain-only antibodies
#553ANTIBODIES AGAINST A PROTEIN ENTITLED 161P2F10B
#554Production of heterologous protein in the avian oviduct
#555TREATMENT OF CANCER WITH ANTI-IL-1alpha ANTIBODIES
#556Biological products
#557Fc receptor binding proteins
#558THERAPEUTIC COMBINATIONS OF ANTI-IGF-1R ANTIBODIES AND OTHER COMPOUNDS
#559Amyloid-beta globulomer antibodies
#560Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences
#561TNFα-neutralizing antibodies
#562Use of goat serum for veterinary treatment
#563Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of using the same
#564Monoclonal antibody capable of binding integrin alpha 10 beta 1
#565Prevention and treatment of complement-associated eye conditions
#566Antibodies and Improved Test Sample Handling Methods for Use in Assays for Myeloperoxidase
#567Binding moieties based on shark ignar domains
#568Neutralising antibody molecules having specificity for human IL-17
#569Novel Rabbit Antibody Humanization Methods and Humanized Rabbit Antibodies
#570Antibodies to IL-6 and use thereof
#571Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin A peptides
#572Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction
#573DETERMINING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY USING BOTULINUM TOXIN A PEPTIDES
#574Human anti-B7RP1 neutralizing antibodies
#575Use of Goat Serum for Veterinary Treatment
#576ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F AND METHODS OF USING THE SAME
#577Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#578Production of a transgenic avian by cytoplasmic injection
#579BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
#580BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
#581Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
#582BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
#583RECOMBINANT PLATELET COLLAGEN RECEPTOR GLYCOPROTEIN VI AND ITS PHARMACEUTICAL USE
#584Fraction comprising guinea pig immunoglobulin e and antibody
#585Antibodies against epitopes with homology to self antigens, methods of preparation
#586Prokaryotically produced antibodies and uses thereof
#587Biological products
#588Recombinant DNA-molecule complex for the expression of anti-human-interferon-gamma chimeric antibodies or antibody fragments
#589Production of motif-specific and context-independent antibodies using peptide libraries as antigens
#590Prokaryotically produced antibodies and uses thereof
#591Anti-VEGF antibodies
#592Antibodies and related molecules that bind to 161P2F10B proteins
#593Hypoxia induced mitogenic factor
#594Staphylococcal immunotherapeutics via donor selection and donor stimulation
#595TNFα-neutralizing antibodies
#596Monoclonal antibody capable of binding integrin alpha 10 beta 1
#597Dairy-derived anticholesterol immunoglobulin to lower dietary cholesterol in humans
#598Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of using the same
#599Therapeutic adjuvant
#600Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer